Sarepta Spikes 20%, Feuerstein Says Company Can Win FDA Drug Approval By: Benzinga via Benzinga April 28, 2016 at 11:15 AM EDT Shares of Sarepta Therapeutics Inc (NASDAQ: SRPT) spiked higher by around 20 percent Thursday morning after The Street's biotech ... Read More >> Related Stocks: Sarepta Therapeutics